OFIX
Orthofix Medical Inc.
Price Chart
Latest Quote
$8.85
-0.10 (-1.12%)
Current Price
| Previous Close | $8.95 |
| Open | $8.85 |
| Day High | $8.85 |
| Day Low | $8.85 |
| Volume | 8,089 |
Stock Information
| Shares Outstanding | 40.42M |
| Total Debt | $262.26M |
| Cash Equivalents | $120.28M |
| Revenue | $825.37M |
| Net Income | $-60.01M |
| Sector | Healthcare |
| Industry | Medical Devices |
| Market Cap | $357.73M |
| EPS (TTM) | $-1.50 |
| Exchange | NMS |
đ Comprehensive Analysis
Company Data
| Enterprise Value | $503.75M |
| Sales | $825.37M |
| Income | $-60.01M |
| Book/sh | $10.78 |
| Cash/sh | $2.98 |
| Employees | 2K |
Financial Ratios
| Quick Ratio | 1.60 |
| Current Ratio | 2.87 |
| Debt/Eq | 60.26 |
Returns & Margins
| ROA | -3.25% |
| ROE | -13.43% |
| Gross Margin | 71.01% |
| Operating Margin | -6.75% |
| Profit Margin | -7.27% |
Ownership
| Insider Ownership | 2.20% |
| Institutional Ownership | 92.06% |
| Insider & Institutional transactions data not available | |
Valuation Ratios
| Forward P/E | 12.46 |
| PEG | 48.83 |
| P/S | 0.43 |
| P/B | 0.82 |
Analyst Data
| Recommendation | none |
| Target Price | $15.00 |
Technical Indicators
| SMA20 | $9.50 |
| SMA50 | $11.05 |
| SMA200 | $13.42 |
| RSI | 37.71 |
| ATR | 0.4300 |
| Shares Float | 40.10M |
| Short Float | 5.46% |
| Short Ratio | 4.11 |
| Volatility | 0.71 |
| Rel Volume | 0.02 |
Performance History
| Week | -3.80% |
| Month | -14.99% |
| Quarter | -25.44% |
| 6 Months | -43.12% |
| YTD | -40.36% |
| Year | -14.41% |
| 3 Years | -52.93% |
| 5 Years | -79.02% |
| 10 Years | -79.99% |
Stock Score:
â Premium
Based on debt, profitability, growth, and cash flow metrics
â Premium Feature
Sign up for free to view detailed scoring breakdown â premium is free during our trial period!
Recent Price History
| Date | Close | Volume |
|---|---|---|
| 2026-06-23 | $8.85 | 8,089 |
| 2026-06-22 | $8.95 | 363,500 |
| 2026-06-18 | $9.45 | 504,100 |
| 2026-06-17 | $9.23 | 322,700 |
| 2026-06-16 | $9.41 | 256,800 |
| 2026-06-15 | $9.20 | 298,400 |
| 2026-06-12 | $9.31 | 346,800 |
| 2026-06-11 | $9.23 | 401,300 |
| 2026-06-10 | $9.73 | 266,400 |
| 2026-06-09 | $9.87 | 513,400 |
| 2026-06-08 | $9.69 | 384,500 |
| 2026-06-05 | $10.29 | 324,800 |
| 2026-06-04 | $10.34 | 521,900 |
| 2026-06-03 | $9.72 | 678,600 |
| 2026-06-02 | $9.71 | 529,200 |
| 2026-06-01 | $9.27 | 487,600 |
| 2026-05-29 | $9.27 | 421,100 |
| 2026-05-28 | $9.49 | 511,700 |
| 2026-05-27 | $9.32 | 704,300 |
| 2026-05-26 | $9.77 | 981,200 |
About Orthofix Medical Inc.
Orthofix Medical Inc., together with its subsidiaries, operates as a medical technology company in the United States, Italy, the United Kingdom, France, Germany, Brazil, and internationally. It operates through two segments, Global Spine and Global Limb Reconstruction. The Global Spine segment manufactures, distributes, and provides support services for bone growth stimulation devices that enhance bone fusion; designs, develops, and markets a portfolio of spine fixation implant products for use throughout the spinal column; and offers bone graft substitutes, such as fiber-based and particulate demineralized bone matrices, cellular bone allografts, collagen ceramic matrices, and synthetic bone void fillers in various forms with supporting graft delivery solutions to treat various spinal, orthopedic, and dental conditions. This segment also designs, develops, and markets a portfolio of navigation technologies, including tracked surgical tools, intelligent software, and imaging equipment based on machine-vision and optical innovations; and 7D FLASH Navigation System, a navigation platform for spinal and cranial procedures. The Global Limb Reconstruction segment offers products and solutions for the underserved limb reconstruction market, including deformity correction, limb lengthening, complex fracture management, and limb preservation. This segment also designs, develops, and markets external and internal fixation limb reconstruction products that are coupled with enabling digital technologies to support the entire patient care continuum. It sells its products through distributors and sales representatives to hospitals, healthcare organizations, healthcare providers, ambulatory surgery centers, and out-patient hospitals. The company was formerly known as Orthofix International N.V. and changed its name to Orthofix Medical Inc. in July 2018. Orthofix Medical Inc. was founded in 1980 and is headquartered in Lewisville, Texas.
đ° Latest News
Orthofix Medical (OFIX) Stock Sees Split Analyst Revisions After CMS Reimbursement Reset
Simply Wall St. âĸ 2026-06-18T15:12:43Z
How The Orthofix Medical (OFIX) Narrative Is Resetting After CMS Cuts And Guidance Changes
Simply Wall St. âĸ 2026-06-04T10:09:23Z
Orthofix Medical and 5 More Stocks See Action From Activist Investors
Barrons.com âĸ 2026-05-29T21:14:00Z
How The Orthofix Medical (OFIX) Investment Story Is Resetting After New Guidance And Targets
Simply Wall St. âĸ 2026-05-16T18:12:59Z
Orthofix Medical Inc. (NASDAQ:OFIX) Just Reported, And Analysts Assigned A US$17.25 Price Target
Simply Wall St. âĸ 2026-05-08T12:52:13Z
Orthofix Medical Q1 Earnings Call Highlights
MarketBeat âĸ 2026-05-05T19:27:25Z
Orthofix Medical Inc. Q1 2026 Earnings Call Summary
Moby âĸ 2026-05-05T16:50:43Z
Orthofix (OFIX) Q1 2026 Earnings Transcript
Motley Fool âĸ 2026-05-05T16:17:41Z
How The Orthofix Medical (OFIX) Story Is Shifting After Q4 Models And 2026 Guidance
Simply Wall St. âĸ 2026-04-25T13:03:38Z
Down 12.6% in 4 Weeks, Here's Why You Should You Buy the Dip in Orthofix (OFIX)
Zacks âĸ 2026-03-16T13:35:02Z
Period:
Loading...
Income Statement (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Revenue | ||||
| Reconciled Cost Of Revenue | $201,449,000 | $195,080,000 | $217,215,000 | $99,665,000 |
| Cost Of Revenue | $256,295,000 | $253,606,000 | $260,368,000 | $123,544,000 |
| Total Revenue | $822,312,000 | $799,491,000 | $746,641,000 | $460,713,000 |
| Operating Revenue | $822,312,000 | $799,491,000 | $746,641,000 | $460,713,000 |
| Expenses | ||||
| Interest Expense | $17,488,000 | $29,631,000 | $8,631,000 | $1,288,000 |
| Total Expenses | $904,880,000 | $877,210,000 | $888,402,000 | $489,581,000 |
| Other Income Expense | $9,246,000 | $-16,525,000 | $1,713,000 | $12,450,000 |
| Other Non Operating Income Expenses | $8,106,000 | $-9,625,000 | $-938,000 | $-3,150,000 |
| Net Non Operating Interest Income Expense | $-17,488,000 | $-29,631,000 | $-8,631,000 | $-1,288,000 |
| Interest Expense Non Operating | $17,488,000 | $29,631,000 | $8,631,000 | $1,288,000 |
| Operating Expense | $648,585,000 | $623,604,000 | $628,034,000 | $366,037,000 |
| Selling And Marketing Expense | - | - | $385,736,000 | $228,810,000 |
| General And Administrative Expense | - | - | $144,659,000 | $79,966,000 |
| Income & Earnings | ||||
| Net Income From Continuing Operation Net Minority Interest | $-92,192,000 | $-125,997,000 | $-151,395,000 | $-19,749,000 |
| Net Interest Income | $-17,488,000 | $-29,631,000 | $-8,631,000 | $-1,288,000 |
| Normalized Income | $-93,092,600 | $-120,546,000 | $-153,489,290 | $-32,073,000 |
| Net Income From Continuing And Discontinued Operation | $-92,192,000 | $-125,997,000 | $-151,395,000 | $-19,749,000 |
| Total Operating Income As Reported | $-81,428,000 | $-84,619,000 | $-139,110,000 | $-13,268,000 |
| Net Income Common Stockholders | $-92,192,000 | $-125,997,000 | $-151,395,000 | $-19,749,000 |
| Net Income | $-92,192,000 | $-125,997,000 | $-151,395,000 | $-19,749,000 |
| Net Income Including Noncontrolling Interests | $-92,192,000 | $-125,997,000 | $-151,395,000 | $-19,749,000 |
| Net Income Continuous Operations | $-92,192,000 | $-125,997,000 | $-151,395,000 | $-19,749,000 |
| Pretax Income | $-90,810,000 | $-123,875,000 | $-148,679,000 | $-17,706,000 |
| Special Income Charges | $1,140,000 | $-6,900,000 | $2,651,000 | $15,600,000 |
| Operating Income | $-82,568,000 | $-77,719,000 | $-141,761,000 | $-28,868,000 |
| Depreciation Amortization Depletion Income Statement | $28,409,000 | $17,436,000 | $17,408,000 | $8,196,000 |
| Depreciation And Amortization In Income Statement | $28,409,000 | $17,436,000 | $17,408,000 | $8,196,000 |
| Amortization Of Intangibles Income Statement | $28,409,000 | $17,436,000 | $17,408,000 | $8,196,000 |
| Gross Profit | $566,017,000 | $545,885,000 | $486,273,000 | $337,169,000 |
| Per Share | ||||
| Diluted EPS | $-2.33 | $-3.30 | $-4.12 | $-0.98 |
| Basic EPS | $-2.33 | $-3.30 | $-4.12 | $-0.98 |
| Other | ||||
| Tax Effect Of Unusual Items | $239,400 | $-1,449,000 | $556,710 | $3,276,000 |
| Tax Rate For Calcs | $0 | $0 | $0 | $0 |
| Normalized EBITDA (Bullshit earnings) | $8,793,000 | $-11,382,000 | $-82,138,000 | $57,000 |
| Total Unusual Items | $1,140,000 | $-6,900,000 | $2,651,000 | $15,600,000 |
| Total Unusual Items Excluding Goodwill | $1,140,000 | $-6,900,000 | $2,651,000 | $15,600,000 |
| Reconciled Depreciation | $83,255,000 | $75,962,000 | $60,561,000 | $32,075,000 |
| EBITDA (Bullshit earnings) | $9,933,000 | $-18,282,000 | $-79,487,000 | $15,657,000 |
| EBIT | $-73,322,000 | $-94,244,000 | $-140,048,000 | $-16,418,000 |
| Diluted Average Shares | $39,600,000 | $38,100,000 | $36,729,258 | $20,100,000 |
| Basic Average Shares | $39,600,000 | $38,100,000 | $36,729,258 | $20,100,000 |
| Diluted NI Availto Com Stockholders | $-92,192,000 | $-125,997,000 | $-151,395,000 | $-19,749,000 |
| Tax Provision | $1,382,000 | $2,122,000 | $2,716,000 | $2,043,000 |
| Restructuring And Mergern Acquisition | $-1,140,000 | $6,900,000 | $-2,700,000 | $-17,200,000 |
| Amortization | $28,409,000 | $17,436,000 | $17,408,000 | $8,196,000 |
| Research And Development | $65,847,000 | $73,643,000 | $80,231,000 | $49,065,000 |
| Selling General And Administration | $554,329,000 | $532,525,000 | $530,395,000 | $308,776,000 |
| Other Special Charges | - | - | $49,000 | $1,600,000 |
| Impairment Of Capital Assets | - | - | $0 | $0 |
| Other Gand A | - | - | $144,659,000 | $79,966,000 |
Fetched: 2026-06-23
Balance Sheet (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Assets | ||||
| Net Tangible Assets | $182,338,000 | $209,387,000 | $286,306,000 | $218,155,000 |
| Total Assets | $850,647,000 | $893,294,000 | $925,315,000 | $458,629,000 |
| Total Non Current Assets | $433,800,000 | $460,009,000 | $504,872,000 | $202,639,000 |
| Other Non Current Assets | $36,702,000 | $26,468,000 | $33,388,000 | $25,705,000 |
| Goodwill And Other Intangible Assets | $267,699,000 | $293,737,000 | $312,424,000 | $118,705,000 |
| Other Intangible Assets | $72,765,000 | $98,803,000 | $117,490,000 | $47,388,000 |
| Current Assets | $416,847,000 | $433,285,000 | $420,443,000 | $255,990,000 |
| Other Current Assets | $23,667,000 | $23,382,000 | $32,422,000 | $22,283,000 |
| Restricted Cash | $3,090,000 | $2,500,000 | $4,650,000 | $0 |
| Inventory | $172,319,000 | $189,452,000 | $222,166,000 | $100,150,000 |
| Receivables | $135,746,000 | $134,713,000 | $128,098,000 | $82,857,000 |
| Accounts Receivable | $135,746,000 | $134,713,000 | $128,098,000 | $82,857,000 |
| Allowance For Doubtful Accounts Receivable | $-8,308,000 | $-7,418,000 | $-7,130,000 | $-6,419,000 |
| Gross Accounts Receivable | $144,054,000 | $142,131,000 | $135,228,000 | $89,276,000 |
| Cash Cash Equivalents And Short Term Investments | $82,025,000 | $83,238,000 | $33,107,000 | $50,700,000 |
| Cash And Cash Equivalents | $82,025,000 | $83,238,000 | $33,107,000 | $50,700,000 |
| Non Current Deferred Assets | - | - | - | - |
| Non Current Deferred Taxes Assets | - | - | - | - |
| Prepaid Assets | - | - | - | - |
| Debt | ||||
| Net Debt | $75,366,000 | $73,777,000 | $61,250,000 | - |
| Total Debt | $178,435,000 | $179,628,000 | $117,074,000 | $21,529,000 |
| Long Term Debt And Capital Lease Obligation | $174,451,000 | $174,850,000 | $111,639,000 | $19,239,000 |
| Long Term Debt | $157,391,000 | $157,015,000 | $93,107,000 | - |
| Current Debt And Capital Lease Obligation | $3,984,000 | $4,778,000 | $5,435,000 | $2,290,000 |
| Current Debt | - | - | $1,250,000 | - |
| Other Current Borrowings | - | - | $1,250,000 | - |
| Liabilities | ||||
| Total Liabilities Net Minority Interest | $400,610,000 | $390,170,000 | $326,585,000 | $121,769,000 |
| Total Non Current Liabilities Net Minority Interest | $230,128,000 | $221,542,000 | $161,362,000 | $38,145,000 |
| Other Non Current Liabilities | $55,677,000 | $46,692,000 | $49,723,000 | $18,906,000 |
| Current Liabilities | $170,482,000 | $168,628,000 | $165,223,000 | $83,624,000 |
| Other Current Liabilities | $4,290,000 | $7,100,000 | $1,000,000 | $1,000,000 |
| Payables And Accrued Expenses | $162,208,000 | $156,750,000 | $158,788,000 | $81,334,000 |
| Payables | $71,222,000 | $66,505,000 | $73,094,000 | $38,818,000 |
| Other Payable | $9,221,000 | $9,288,000 | $7,152,000 | $4,634,000 |
| Total Tax Payable | $3,609,000 | $8,414,000 | $7,585,000 | $6,586,000 |
| Accounts Payable | $58,392,000 | $48,803,000 | $58,357,000 | $27,598,000 |
| Equity | ||||
| Common Stock Equity | $450,037,000 | $503,124,000 | $598,730,000 | $336,860,000 |
| Total Equity Gross Minority Interest | $450,037,000 | $503,124,000 | $598,730,000 | $336,860,000 |
| Stockholders Equity | $450,037,000 | $503,124,000 | $598,730,000 | $336,860,000 |
| Gains Losses Not Affecting Retained Earnings | $618,000 | $-4,302,000 | $-1,293,000 | $-1,376,000 |
| Other Equity Adjustments | $618,000 | $-4,302,000 | $-1,293,000 | $-1,376,000 |
| Retained Earnings | $-368,333,000 | $-276,141,000 | $-150,144,000 | $1,251,000 |
| Other | ||||
| Ordinary Shares Number | $39,834,000 | $38,486,000 | $37,165,000 | $20,162,000 |
| Share Issued | $39,834,000 | $38,486,000 | $37,165,000 | $20,162,000 |
| Tangible Book Value | $182,338,000 | $209,387,000 | $286,306,000 | $218,155,000 |
| Invested Capital | $607,428,000 | $660,139,000 | $693,087,000 | $336,860,000 |
| Working Capital | $246,365,000 | $264,657,000 | $255,220,000 | $172,366,000 |
| Capital Lease Obligations | $21,044,000 | $22,613,000 | $22,717,000 | $21,529,000 |
| Total Capitalization | $607,428,000 | $660,139,000 | $691,837,000 | $336,860,000 |
| Additional Paid In Capital | $813,769,000 | $779,718,000 | $746,450,000 | $334,969,000 |
| Capital Stock | $3,983,000 | $3,849,000 | $3,717,000 | $2,016,000 |
| Common Stock | $3,983,000 | $3,849,000 | $3,717,000 | $2,016,000 |
| Long Term Capital Lease Obligation | $17,060,000 | $17,835,000 | $18,532,000 | $19,239,000 |
| Current Capital Lease Obligation | $3,984,000 | $4,778,000 | $4,185,000 | $2,290,000 |
| Current Accrued Expenses | $90,986,000 | $90,245,000 | $85,694,000 | $42,516,000 |
| Goodwill | $194,934,000 | $194,934,000 | $194,934,000 | $71,317,000 |
| Net PPE | $129,399,000 | $139,804,000 | $159,060,000 | $58,229,000 |
| Accumulated Depreciation | $-250,737,000 | $-212,242,000 | $-188,625,000 | $-162,996,000 |
| Gross PPE | $380,136,000 | $352,046,000 | $347,685,000 | $221,225,000 |
| Construction In Progress | $23,235,000 | $22,693,000 | $41,751,000 | $4,515,000 |
| Other Properties | $213,813,000 | $197,770,000 | $177,529,000 | $115,883,000 |
| Machinery Furniture Equipment | $138,688,000 | $127,709,000 | $124,302,000 | $96,960,000 |
| Buildings And Improvements | $4,400,000 | $3,874,000 | $4,103,000 | $3,867,000 |
| Properties | $0 | $0 | $0 | $0 |
| Finished Goods | $86,199,000 | $105,352,000 | $140,266,000 | $63,872,000 |
| Work In Process | $63,255,000 | $56,920,000 | $53,510,000 | $19,243,000 |
| Raw Materials | $22,865,000 | $27,180,000 | $28,390,000 | $17,035,000 |
Fetched: 2026-06-23
Cash Flow Statement (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Free Cash Flow | ||||
| Free Cash Flow | $-1,279,000 | $-9,086,000 | $-107,803,000 | $-34,698,000 |
| Operating Activities | ||||
| Operating Cash Flow | $33,347,000 | $25,790,000 | $-45,753,000 | $-11,538,000 |
| Cash Flow From Continuing Operating Activities | $33,347,000 | $25,790,000 | $-45,753,000 | $-11,538,000 |
| Operating Gains Losses | $1,140,000 | $2,025,000 | $2,300,000 | $2,072,000 |
| Investing Activities | ||||
| Capital Expenditure | $-34,626,000 | $-34,876,000 | $-62,050,000 | $-23,160,000 |
| Investing Cash Flow | $-34,598,000 | $-27,580,000 | $-33,131,000 | $-24,534,000 |
| Cash Flow From Continuing Investing Activities | $-34,598,000 | $-27,580,000 | $-33,131,000 | $-24,534,000 |
| Net Other Investing Changes | $28,000 | $-100,000 | $-500,000 | $-1,374,000 |
| Capital Expenditure Reported | $-34,626,000 | $-34,876,000 | $-62,050,000 | $-23,160,000 |
| Financing Activities | ||||
| Issuance Of Capital Stock | $5,929,000 | $6,257,000 | $5,127,000 | $4,337,000 |
| Financing Cash Flow | $-786,000 | $50,709,000 | $65,322,000 | $-78,000 |
| Cash Flow From Continuing Financing Activities | $-786,000 | $50,709,000 | $65,322,000 | $-78,000 |
| Net Other Financing Charges | $-5,953,000 | $-9,942,000 | $-7,754,000 | $-1,821,000 |
| Net Common Stock Issuance | $5,929,000 | $6,257,000 | $5,127,000 | $4,337,000 |
| Common Stock Issuance | $5,929,000 | $6,257,000 | $5,127,000 | $4,337,000 |
| Other | ||||
| Repayment Of Debt | $-762,000 | $-143,206,000 | $-106,551,000 | $-2,594,000 |
| Issuance Of Debt | $0 | $197,600,000 | $174,500,000 | $0 |
| End Cash Position | $85,115,000 | $85,738,000 | $37,757,000 | $50,700,000 |
| Beginning Cash Position | $85,738,000 | $37,757,000 | $50,700,000 | $87,847,000 |
| Effect Of Exchange Rate Changes | $1,414,000 | $-938,000 | $619,000 | $-997,000 |
| Changes In Cash | $-2,037,000 | $48,919,000 | $-13,562,000 | $-36,150,000 |
| Net Issuance Payments Of Debt | $-762,000 | $54,394,000 | $67,949,000 | $-2,594,000 |
| Net Long Term Debt Issuance | $-762,000 | $54,394,000 | $67,949,000 | $-2,594,000 |
| Long Term Debt Payments | $-762,000 | $-143,206,000 | $-106,551,000 | $-2,594,000 |
| Long Term Debt Issuance | $0 | $197,600,000 | $174,500,000 | $0 |
| Net Investment Purchase And Sale | $0 | $7,396,000 | $0 | $126,000 |
| Sale Of Investment | $0 | $7,396,000 | $0 | $126,000 |
| Net Business Purchase And Sale | $0 | $0 | $29,419,000 | $-1,500,000 |
| Sale Of Business | $0 | $0 | $29,419,000 | $0 |
| Change In Working Capital | $-20,157,000 | $-19,251,000 | $-53,964,000 | $-44,142,000 |
| Change In Other Working Capital | $-4,231,000 | $-8,728,000 | $27,000 | $-6,402,000 |
| Change In Other Current Liabilities | $-2,268,000 | $9,527,000 | $4,069,000 | $627,000 |
| Change In Payables And Accrued Expense | $2,599,000 | $-5,571,000 | $8,642,000 | $2,282,000 |
| Change In Payable | $2,599,000 | $-5,571,000 | $8,642,000 | $2,282,000 |
| Change In Account Payable | $2,599,000 | $-5,571,000 | $8,642,000 | $2,282,000 |
| Change In Prepaid Assets | $-3,926,000 | $593,000 | $1,760,000 | $-874,000 |
| Change In Inventory | $-10,748,000 | $-5,546,000 | $-58,051,000 | $-33,040,000 |
| Change In Receivables | $-1,583,000 | $-9,526,000 | $-10,411,000 | $-6,735,000 |
| Changes In Account Receivables | $-1,583,000 | $-9,526,000 | $-10,411,000 | $-6,735,000 |
| Other Non Cash Items | $-690,000 | $30,460,000 | $32,063,000 | $-17,553,000 |
| Stock Based Compensation | $28,688,000 | $32,455,000 | $35,707,000 | $18,443,000 |
| Provisionand Write Offof Assets | $33,080,000 | $28,253,000 | $28,396,000 | $17,002,000 |
| Deferred Tax | $223,000 | $1,883,000 | $579,000 | $314,000 |
| Deferred Income Tax | $223,000 | $1,883,000 | $579,000 | $314,000 |
| Depreciation Amortization Depletion | $83,255,000 | $75,962,000 | $60,561,000 | $32,075,000 |
| Depreciation And Amortization | $83,255,000 | $75,962,000 | $60,561,000 | $32,075,000 |
| Depreciation | $83,255,000 | $75,962,000 | $60,561,000 | $32,075,000 |
| Gain Loss On Sale Of PPE | $1,140,000 | $2,025,000 | $2,300,000 | $2,072,000 |
| Net Income From Continuing Operations | $-92,192,000 | $-125,997,000 | $-151,395,000 | $-19,749,000 |
| Purchase Of Business | - | $0 | $0 | $-1,500,000 |
| Amortization Cash Flow | - | $19,000,000 | $18,900,000 | $9,400,000 |
| Amortization Of Intangibles | - | $19,000,000 | $18,900,000 | $9,400,000 |
| Purchase Of Investment | - | - | $0 | $0 |
| Asset Impairment Charge | - | - | $0 | $0 |
| Net Short Term Debt Issuance | - | - | - | - |
| Short Term Debt Payments | - | - | - | - |
| Short Term Debt Issuance | - | - | - | - |
Fetched: 2026-06-23